📰 Formp News
Formp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Formp. Real-time updates on events, politics, business and more.
May 2, 2024
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $2.48 and traded as low as $2.25. Oramed Pharmaceuticals shares last traded at $2.34, with a volume of 44,022 shares. Oramed Pharmaceuticals […]
February 22, 2024
Rathbones Group PLC bought a new stake in shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 289,803 shares of the biotechnology company’s stock, valued at approximately $756,000. Rathbones Group PLC owned approximately 0.72% […]
January 25, 2024
N.E.W. Advisory Services LLC acquired a new stake in shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Free Report) during the third quarter, according to its most recent disclosure with the SEC. The fund acquired 12,960 shares of the biotechnology company’s stock, valued at approximately $34,000. A number of other large investors also recently added to […]
January 20, 2024
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $2.61 and traded as low as $2.17. Oramed Pharmaceuticals shares last traded at $2.23, with a volume of 80,966 shares. Analyst Ratings Changes Separately, StockNews.com began coverage on […]
January 13, 2024
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Free Report)’s share price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.66 and traded as low as $2.21. Oramed Pharmaceuticals shares last traded at $2.32, with a volume of 161,057 shares traded. Wall Street Analysts Forecast Growth […]
July 29, 2023
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Free Report) was the recipient of a significant drop in short interest in July. As of July 15th, there was short interest totalling 677,000 shares, a drop of 15.1% from the June 30th total of 797,800 shares. Based on an average trading volume of 869,200 shares, the days-to-cover ratio […]
May 18, 2023
Landscape Capital Management L.L.C. acquired a new position in shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 26,220 shares of the biotechnology company’s stock, valued at approximately $315,000. Landscape Capital Management L.L.C. owned […]
May 11, 2023
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $4.88 and traded as low as $2.81. Oramed Pharmaceuticals shares last traded at $3.03, with a volume of 740,289 shares trading hands. Wall Street Analyst Weigh In ORMP […]
April 22, 2023
StockNews.com upgraded shares of Oramed Pharmaceuticals (NASDAQ:ORMP – Get Rating) from a sell rating to a hold rating in a report issued on Tuesday morning. Other analysts have also recently issued research reports about the stock. Canaccord Genuity Group cut shares of Oramed Pharmaceuticals from a buy rating to a hold rating and cut their […]
April 18, 2023
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) saw a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 789,300 shares, a decline of 19.9% from the March 15th total of 985,700 shares. Based on an average trading volume of 1,690,000 shares, the days-to-cover ratio is […]